摘要
Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy.
原文 | 英語 |
---|---|
頁(從 - 到) | 1045-1047 |
頁數 | 3 |
期刊 | Clinical and Translational Science |
卷 | 13 |
發行號 | 6 |
DOIs | |
出版狀態 | 已發佈 - 11月 2020 |
ASJC Scopus subject areas
- 一般神經科學
- 一般生物化學,遺傳學和分子生物學
- 藥理學、毒理學和藥劑學 (全部)